Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04797403 · ClinicalTrials.gov registry record · NA

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

A NA study of Hypertension and Cognitive Decline, sponsored by Tulane University.

Active
Registry status
NA
Development phase
1,306
Enrollment target
1
Study location

NCT04797403: Active NA study of Hypertension and Cognitive Decline, sponsored by Tulane University.

NCT04797403 is a NA study of Hypertension and Cognitive Decline that is active but no longer recruiting, run by Tulane University. The registered enrollment target is 1,306 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04797403, a NA study of Hypertension and Cognitive Decline, is active but no longer recruiting, sponsored by Tulane University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,306 participants
Enrollment target
1
Study location

Study Summary

The study will test a multifaceted strategy for implementing an intensive blood pressure intervention protocol targeting systolic BP \<120 mmHg on cognitive decline in racial minority and low-income hypertensive patients in primary care. The proposed study will generate urgently needed data on effective, adoptable, and equitable intervention strategies to reduce blood pressure-related cognitive decline in low- income and minority populations. If proven effective, the implementation strategy for intensive blood pressure reduction could be adapted and scaled up in diverse primary care settings to prevent cognitive decline and clinical dementia.

Primary Outcome

The net difference in mean change of global cognitive composite z-score over an average 36 months between intervention and enhanced usual care groups

Interventions

  • BEHAVIORAL Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm

Study Locations (1)

Louisiana

  • Tulane University - New Orleans

Trial Details

FieldValue
Enrollment Target 1,306 participants
Start Date 2019-10-22
Est. Completion 2026-08
Phase NA
Tulane University

73 total trials

What the registry record for NCT04797403 still lists

NCT04797403 is an interventional study that assigns participants to a tested intervention. Its 1,306 participants enrollment target places it among the larger protocols in the corpus, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (63% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm is the first listed.

NCT04797403 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT04797403 about?

NCT04797403 is a clinical study titled "Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline". The study will test a multifaceted strategy for implementing an intensive blood pressure intervention protocol targeting systolic BP \<120 mmHg on cognitive decline in racial minority and low-income hypertensive patients in primary care. The proposed study will generate urgently needed data on effec...

What is the current status of trial NCT04797403?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,306 participants. The study started on 2019-10-22. Estimated completion is 2026-08.

What conditions does trial NCT04797403 study?

This clinical trial studies the following conditions: Hypertension, Cognitive Decline.

What interventions are being tested in trial NCT04797403?

The interventions under investigation include: Stepped-care protocol adapted from the SPRINT intensive-treatment algorithm (BEHAVIORAL).

Who is sponsoring clinical trial NCT04797403?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04797403 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04797403's enrollment target sits among peer trials

1,306 51st of 470 higher than 420 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06517901 · 1,306 participants · NA

    Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

  • NCT04171323 · 1,305 participants · NA

    The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia

  • NCT06136624 · 1,310 participants · Phase 3

    Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  • NCT06556433 · 1,312 participants · NA

    Family-Based Financial Incentives Intervention for Smoking Cessation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04797403, the US trial registry maintained by the National Library of Medicine. NCT04797403 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.